Capstone Investment Advisors LLC bought a new stake in Privia Health Group, Inc. (NASDAQ:PRVA – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 31,832 shares of the company’s stock, valued at approximately $819,000.
A number of other institutional investors have also bought and sold shares of the company. BlackRock Inc. acquired a new position in shares of Privia Health Group in the 2nd quarter valued at about $550,684,000. Durable Capital Partners LP grew its stake in Privia Health Group by 1.8% during the third quarter. Durable Capital Partners LP now owns 11,691,685 shares of the company’s stock worth $291,123,000 after purchasing an additional 203,842 shares during the period. Rubicon Founders LLC bought a new stake in Privia Health Group in the second quarter worth approximately $153,635,863. State Street Corp lifted its stake in Privia Health Group by 1.5% in the second quarter. State Street Corp now owns 4,171,069 shares of the company’s stock valued at $95,935,000 after buying an additional 61,853 shares during the period. Finally, Van Berkom & Associates Inc. boosted its holdings in shares of Privia Health Group by 5.4% during the 1st quarter. Van Berkom & Associates Inc. now owns 4,053,043 shares of the company’s stock worth $83,371,000 after buying an additional 208,787 shares in the last quarter. Institutional investors own 94.48% of the company’s stock.
Insider Activity
In other Privia Health Group news, CFO David Mountcastle sold 21,275 shares of the stock in a transaction on Thursday, July 9th. The stock was sold at an average price of $27.67, for a total transaction of $588,679.25. Following the completion of the transaction, the chief financial officer directly owned 164,853 shares of the company’s stock, valued at approximately $4,561,482.51. This represents a 11.43% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Matthew Shawn Morris sold 53,722 shares of the business’s stock in a transaction dated Monday, July 6th. The shares were sold at an average price of $27.24, for a total value of $1,463,387.28. Following the completion of the sale, the director owned 68,188 shares in the company, valued at $1,857,441.12. This represents a 44.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 327,886 shares of company stock worth $8,628,256. Insiders own 5.70% of the company’s stock.
Analysts Set New Price Targets
Check Out Our Latest Research Report on PRVA
Privia Health Group Stock Down 0.3%
Shares of NASDAQ PRVA opened at $20.79 on Friday. Privia Health Group, Inc. has a twelve month low of $19.53 and a twelve month high of $28.82. The stock’s 50 day moving average price is $24.33 and its 200-day moving average price is $23.18. The company has a market capitalization of $2.66 billion, a PE ratio of 99.00, a PEG ratio of 1.64 and a beta of 0.85.
Privia Health Group (NASDAQ:PRVA – Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.12. The firm had revenue of $632.63 million during the quarter, compared to analyst estimates of $597.33 million. Privia Health Group had a return on equity of 3.52% and a net margin of 1.19%.The business’s revenue was up 21.4% compared to the same quarter last year. During the same period last year, the firm posted $0.24 EPS. As a group, research analysts expect that Privia Health Group, Inc. will post 0.27 EPS for the current fiscal year.
About Privia Health Group
Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.
Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.
Featured Stories
- Five stocks we like better than Privia Health Group
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Want to see what other hedge funds are holding PRVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Privia Health Group, Inc. (NASDAQ:PRVA – Free Report).
Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
